205 related articles for article (PubMed ID: 12926584)
1. Probabilistic sensitivity analysis for decision trees with multiple branches: use of the Dirichlet distribution in a Bayesian framework.
Briggs AH; Ades AE; Price MJ
Med Decis Making; 2003; 23(4):341-50. PubMed ID: 12926584
[TBL] [Abstract][Full Text] [Related]
2. Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section.
Cooper NJ; Sutton AJ; Abrams KR
Stat Methods Med Res; 2002 Dec; 11(6):491-512. PubMed ID: 12516986
[TBL] [Abstract][Full Text] [Related]
3. Large-sample Bayesian posterior distributions for probabilistic sensitivity analysis.
Hazen GB; Huang M
Med Decis Making; 2006; 26(5):512-34. PubMed ID: 16997928
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity analysis on a chance node with more than two branches.
Sendi PP; Clemen RT
Med Decis Making; 1999; 19(4):499-502. PubMed ID: 10520688
[TBL] [Abstract][Full Text] [Related]
5. [Decision analysis in radiology using Markov models].
Golder W
Rofo; 2000 Jan; 172(1):80-5. PubMed ID: 10719468
[TBL] [Abstract][Full Text] [Related]
6. Bayesian methods in cost-effectiveness studies: objectivity, computation and other relevant aspects.
Armero C; García-Donato G; López-Quílez A
Health Econ; 2010 Jun; 19(6):629-43. PubMed ID: 19424994
[TBL] [Abstract][Full Text] [Related]
7. A Bayesian model averaging approach for cost-effectiveness analyses.
Conigliani C; Tancredi A
Health Econ; 2009 Jul; 18(7):807-21. PubMed ID: 18792078
[TBL] [Abstract][Full Text] [Related]
8. A Bayesian approach to stochastic cost-effectiveness analysis.
Briggs AH
Health Econ; 1999 May; 8(3):257-61. PubMed ID: 10348420
[TBL] [Abstract][Full Text] [Related]
9. A Bayesian approach to sensitivity analysis.
Felli JC; Hazen GB
Health Econ; 1999 May; 8(3):263-8. PubMed ID: 10348421
[TBL] [Abstract][Full Text] [Related]
10. Calibration of complex models through Bayesian evidence synthesis: a demonstration and tutorial.
Jackson CH; Jit M; Sharples LD; De Angelis D
Med Decis Making; 2015 Feb; 35(2):148-61. PubMed ID: 23886677
[TBL] [Abstract][Full Text] [Related]
11. A Bayesian approach to probabilistic sensitivity analysis in structured benefit-risk assessment.
Waddingham E; Mt-Isa S; Nixon R; Ashby D
Biom J; 2016 Jan; 58(1):28-42. PubMed ID: 25631038
[TBL] [Abstract][Full Text] [Related]
12. Use of influence diagrams to structure medical decisions.
Nease RF; Owens DK
Med Decis Making; 1997; 17(3):263-75. PubMed ID: 9219186
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity Analysis in Sequential Decision Models.
Chen Q; Ayer T; Chhatwal J
Med Decis Making; 2017 Feb; 37(2):243-252. PubMed ID: 27681992
[TBL] [Abstract][Full Text] [Related]
14. Modelling medical decisions in DynaMoL: a new general framework of dynamic decision analysis.
Leong TY; Cao C
Stud Health Technol Inform; 1998; 52 Pt 1():483-7. PubMed ID: 10384503
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in the United Kingdom.
Nazir J; Maman K; Neine ME; Briquet B; Odeyemi IA; Hakimi Z; Garnham A; Aballéa S
Value Health; 2015 Sep; 18(6):783-90. PubMed ID: 26409605
[TBL] [Abstract][Full Text] [Related]
16. Need for speed: an efficient algorithm for calculation of single-parameter expected value of partial perfect information.
Sadatsafavi M; Bansback N; Zafari Z; Najafzadeh M; Marra C
Value Health; 2013; 16(2):438-48. PubMed ID: 23538197
[TBL] [Abstract][Full Text] [Related]
17. Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling.
Spiegelhalter DJ; Best NG
Stat Med; 2003 Dec; 22(23):3687-709. PubMed ID: 14652869
[TBL] [Abstract][Full Text] [Related]
18. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease.
Briggs AH; Goeree R; Blackhouse G; O'Brien BJ
Med Decis Making; 2002; 22(4):290-308. PubMed ID: 12150595
[TBL] [Abstract][Full Text] [Related]
19. Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI).
Barton GR; Briggs AH; Fenwick EA
Value Health; 2008; 11(5):886-97. PubMed ID: 18489513
[TBL] [Abstract][Full Text] [Related]
20. Evidence synthesis, parameter correlation and probabilistic sensitivity analysis.
Ades AE; Claxton K; Sculpher M
Health Econ; 2006 Apr; 15(4):373-81. PubMed ID: 16389628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
